Tesamorelin

What Tesamorelin Is — and What It's Approved For

Tesamorelin is a prescription medicine that works with your body. It gently signals your brain to release more of your own natural growth hormone — instead of putting synthetic hormones into you. The FDA approved it (brand name Egrifta) to reduce stubborn deep belly fat in adults with a specific condition. Using it for any other goal is called "off-label," which simply means a licensed doctor looks at your health first and decides whether it's a safe, legal fit for you.

• Class: growth-hormone-releasing hormone (GHRH) analog
• FDA-approved use: visceral fat reduction in HIV-associated lipodystrophy
• Prescription-only — never sold for self-directed use
• Any other use is off-label and needs individual physician evaluation

How Tesamorelin Works — In Plain Terms

Think of it as a nudge, not a shortcut. Tesamorelin asks your body to make its own growth hormone, on its own natural schedule. That growth hormone then tells your liver to release a helper called IGF-1 — and IGF-1 is the part that helps your body tap into stored deep belly fat. Because it uses your body's own system, the goal of supervised care is simple: keep your levels in a healthy range, never too high.

• Signals your brain (the pituitary) to release growth hormone
• Keeps your body's natural rhythm — no synthetic hormone added
• Raises IGF-1, the helper that lets your body use stored fat
• Studied for reducing deep belly (visceral) fat

Why It's Done as a Set, Supervised Course

Tesamorelin isn't meant to be taken forever. It works best as a set course — often a few months — with simple lab checks along the way. The reasons are straightforward: your body responds better to a defined course, your levels need to stay in a safe range, and your doctor reviews how you're doing before continuing. Your exact dose and schedule are chosen for you, not copied from a one-size-fits-all formula, because the right plan depends on your labs, your goals, and your history.

• Courses are time-limited and monitored, not open-ended
• IGF-1 is checked to stay within a physiologic range
• Benefit and tolerability are reassessed before continuing
• Dose and schedule are individualized by your physician

Typical Clinical Protocol — For Reference Only

For education, here is the protocol from the FDA-approved setting. It is not a prescription or a self-treatment plan — your physician determines your actual regimen, dose, and schedule based on your evaluation and labs.

Your supervised course — a typical structure

Month 1

2 mg

daily, in the evening

Month 2

2 mg

daily, in the evening

Month 3

2 mg

daily, in the evening

Estimated FDA-label dose — your physician sets your actual dose.

UOn an insulin syringe the dose is counted in units. The exact units depend on how your medicine is mixed, so your care team measures and draws it for you.

✓~3-month review: your physician checks IGF-1 and results, then continues, pauses, or adjusts.

Example only

Example vial: 10 mg of tesamorelin

Mixed with 2 mL of sterile water → 5 mg per mL

A 2 mg dose = 0.4 mL ≈ 40 units on an insulin syringe

Illustrative example. Your pharmacy's vial and concentration may be different — your care team measures and draws your exact dose.

🧮 Calculate dosage →

Why physician guidance matters

A specialized, physician-guided program — with individualized dosing, lab monitoring, and adjustments along the way — helps you get the most out of treatment safely. Supervised, tailored care can make a real difference compared with a fixed, unmonitored dose. Individual results vary from person to person, and no outcome is guaranteed.

• FDA-labeled dose: 2 mg given as a single subcutaneous injection once daily
• Site: subcutaneous, into the abdomen, rotating injection sites
• Timing: once daily; an evening schedule is common to align with the body's natural growth-hormone release
• Duration: a time-limited course (commonly evaluated around the 3-month mark), continued only if your physician confirms benefit and safe IGF-1 levels
• Monitoring: IGF-1 and metabolic labs guide whether to continue, pause, or adjust
• Higher 'research' doses and on/off cycles promoted by unregulated sellers are not the FDA-labeled protocol and are not something we provide as a self-directed plan

What a Physician-Supervised Tesamorelin Program Looks Like at Viva

At Viva Medical Center, tesamorelin is only ever part of supervised medical care. Here is how a program is structured:

• A consultation and full health history with a licensed physician
• Baseline lab work to confirm candidacy and safety
• A prescription — an FDA-approved product or, where appropriate, a medication from a licensed compounding pharmacy
• Hands-on training from our clinical team on safe handling and administration
• Scheduled follow-up visits and repeat labs to track response
• An honest conversation about what the evidence does and does not support — with no guarantees

What to Expect — A Realistic Timeline

Body-composition changes from a growth-hormone-axis program are gradual, and they vary from person to person. No outcome is guaranteed. As a general picture of a supervised course:

• Weeks 1–4: your body adjusts; some people notice changes in sleep or energy; visible body-composition change is usually minimal this early
• Weeks 4–8: in studies, reductions in visceral fat become more measurable for people who respond
• Weeks 8–12+: your physician reviews labs and measurements and decides whether to continue, pause, or adjust
• Throughout: results depend on the individual, and lifestyle (nutrition, sleep, activity) matters

Administration, Timing & Storage — Handled With Your Care Team

Tesamorelin is given as a small subcutaneous injection. If it is prescribed for you, we don't hand you a generic internet protocol — your care team provides your medication and supplies, trains you on correct preparation and injection technique, and explains exactly how to store it. Timing is individualized; an evening schedule is common because growth hormone is naturally released during early sleep, and some people feel mildly drowsy afterward. Your physician confirms the right timing for you.

• Subcutaneous injection, with technique trained by our clinical staff
• Medication, supplies, and storage guidance provided to you
• Timing individualized — evening is common to align with natural GH release
• Questions and side effects reviewed at follow-up, not left to guesswork

Safety, Side Effects & Who Should Not Use It

Tesamorelin is generally well tolerated when supervised, but it is a real medication with real considerations. Common, usually mild effects can include injection-site redness, joint aches, fluid retention or swelling, transient drowsiness, and changes in blood sugar. Your physician screens for conditions that make it unsafe.

• Not for use in pregnancy or while breastfeeding
• Not for people with active cancer or a pituitary tumor / pituitary gland problem
• Use caution with diabetes or blood-sugar conditions — glucose is monitored
• Tell your physician about all medications and conditions; report new symptoms promptly

Monitoring & Lab Work

Supervision means measuring, not guessing. Before and during a course your physician may check IGF-1 (to keep growth-hormone activity in a healthy range), fasting glucose or HbA1c, lipids, and other markers based on your history. These labs guide whether to continue and at what dose.

• Baseline labs to confirm candidacy and safety
• IGF-1 monitoring to stay within a physiologic range
• Glucose / HbA1c and lipids as indicated
• Follow-up visits to review response and tolerability

Is Tesamorelin Right for You?

Tesamorelin is studied for visceral fat and body composition, but it is not right for everyone, and lawful use outside its approved indication requires an individual physician determination. The best next step is a consultation: a physician reviews your goals, history, and labs and gives you a clear, honest recommendation — including whether a different option fits you better.

• Adults with visceral-fat or body-composition goals, after evaluation
• Those who want medical supervision, not gray-market products
• People willing to do baseline and follow-up labs
• Not appropriate for everyone — candidacy is determined individually